Guoren Deng

Title: Guoren Deng: Innovator in Breast Cancer Prognostics

Introduction

Guoren Deng is a notable inventor based in Walnut Creek, CA (US). He has made significant contributions to the field of medical research, particularly in the area of breast cancer prognosis. His innovative work focuses on predicting the progression of normal and hyperplastic mammary cells to carcinoma.

Latest Patents

Guoren Deng holds a patent titled "Prognostic methods for prediction of progression of normal and hyperplastic mammary cells to carcinoma." This invention encompasses methods for determining the likelihood that benign hyperplastic breast tissue or normal breast tissue adjacent to carcinoma tissue will become malignant. The methods involve substantially isolating the tissue and determining loss of heterozygosity (LOH) at chromosome 3p24 in the tissue. LOH at chromosome 3p24 serves as a prognostic indicator that the tissue may become malignant. He has 1 patent to his name.

Career Highlights

Guoren Deng is affiliated with the California Pacific Medical Center, where he applies his expertise in medical research. His work has the potential to significantly impact breast cancer diagnosis and treatment.

Collaborations

Some of his notable coworkers include You Lu and Helene S Smith, who contribute to the collaborative efforts in research and innovation at their institution.

Conclusion

Guoren Deng's innovative work in breast cancer prognostics exemplifies the importance of research in improving patient outcomes. His contributions to the field are invaluable and highlight the ongoing efforts to advance medical science.